Go backIncome
Assets
Total liabilities
Employees
ALNADERM
ALNADERM
is not in process of liquidation on Jun 15, 2024
To view all financial indicators, unlock this company.
Income
Financial indicator20202019
Cost of sales
-
-
Remuneration, social insurances, and other benefits
-
(90 EUR)
Depreciation and write-offs on formation expenses on formation expenses, intangible and tangible assets tangible assets
░░░░░░░░
0%
░░░░░░░░
Other operating expenses
░░░░░░░░
0%
░░░░░░░░
Operating profit
░░░░░░░░
0%
░░░░░░░░
Financial income
░░░░░░░░
0%
░░░░░░░░
Recurring financial income
░░░░░░░░
0%
░░░░░░░░
Financial expenses
░░░░░░░░
0%
░░░░░░░░
Recurring financial expenses
░░░░░░░░
0%
░░░░░░░░
Profit before tax
░░░░░░░░
0%
░░░░░░░░
Income tax
░░░░░░░░
0%
░░░░░░░░
Net profit
50.6K EUR
-46%
92.9K EUR
Profit (Loss) to be allocated
░░░░░░░░
0%
░░░░░░░░
Profit (Loss) for the year to be allocated
░░░░░░░░
0%
░░░░░░░░
Allocation to equity
░░░░░░░░
0%
░░░░░░░░
Other
░░░░░░░░
0%
░░░░░░░░
Profit to be distributed
-
812 EUR
Remuneration of the contribution
-
812 EUR
Assets
Financial indicator20202019
Total assets
176K EUR
14%
153K EUR
Non-current assets
░░░░░░░░
0%
░░░░░░░░
Current assets
░░░░░░░░
0%
░░░░░░░░
Total liabilities
Financial indicator20202019
Total liabilities
░░░░░░░░
0%
░░░░░░░░
Equity
░░░░░░░░
0%
░░░░░░░░
Debts
░░░░░░░░
0%
░░░░░░░░
Your trusted source for business data
Socials
English, USA
English, USA